Babar Bashir
Impact in
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
Papers in ⓘ
- Oncology 39
- Cancer Immunotherapy and Biomarkers 12
- CAR-T cell therapy research 9
- Pancreatic and Hepatic Oncology Research 9
- HER2/EGFR in Cancer Research 4
- Co-authors
- Adam E. Snook (10 shared papers)Walter K. Kraft (4 shared papers)Douglas F. Stickle (1 shared paper)Inna Chervoneva (1 shared paper)Scott A. Waldman (6 shared papers)Melissa Wilson (1 shared paper)Jeffrey A. Rappaport (3 shared papers)Thomas M. Churilla (1 shared paper)
- Journals
- Journal of Clinical Oncology (17 papers)Annals of Oncology (8 papers)Cancer Biology & Therapy (4 papers)Cancer Research (3 papers)Clinical and Translational Science (2 papers)
- Partner nations
- United StatesUnited KingdomPakistan
In The Last Decade
Babar Bashir
59 papers receiving 392 citations
Peers
Comparison fields: 5 of 77
- Oncology 178
- Internal Medicine 19
- Immunology 90
- Hepatology 21
- Cancer Research 36
Countries citing papers authored by Babar Bashir
This map shows the geographic impact of Babar Bashir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Babar Bashir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Babar Bashir more than expected).
Fields of papers citing papers by Babar Bashir
This network shows the impact of papers produced by Babar Bashir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Babar Bashir. The network helps show where Babar Bashir may publish in the future.
Co-authors
The 25 scholars most cited alongside Babar Bashir, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 30 | |
| 2 | 2020 | 27 | |
| 3 | 2024 | 22 | |
| 4 | 2019 | 19 | |
| 5 | 2024 | 19 | |
| 6 | 2023 | 18 | |
| 7 | 2016 | 18 | |
| 8 | 2022 | 16 | |
| 9 | 2019 | 15 | |
| 10 | 2022 | 13 | |
| 11 | 2017 | 13 | |
| 12 | 2013 | 12 | |
| 13 | 2015 | 12 | |
| 14 | 2019 | 12 | |
| 15 | 2020 | 12 | |
| 16 | 2021 | 11 | |
| 17 | 2021 | 10 | |
| 18 | 2020 | 8 | |
| 19 | 2022 | 8 | |
| 20 | 2023 | 8 |
About Babar Bashir
Babar Bashir is a scholar working on Oncology, Biological Psychiatry, Immunology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 67 papers that have together received 403 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (12 papers), CAR-T cell therapy research (9 papers), Pancreatic and Hepatic Oncology Research (9 papers), Immunotherapy and Immune Responses (8 papers), Cancer Genomics and Diagnostics (6 papers), Advanced Breast Cancer Therapies (5 papers), Cancer Research and Treatments (4 papers) and HER2/EGFR in Cancer Research (4 papers). The work is most often cited by research in Oncology (178 citations), Internal Medicine (19 citations), Immunology (90 citations), Hepatology (21 citations) and Cancer Research (36 citations). Babar Bashir has collaborated with scholars based in United States, United Kingdom and Pakistan. Frequent co-authors include Adam E. Snook, Walter K. Kraft, Douglas F. Stickle, Inna Chervoneva, Scott A. Waldman, Melissa Wilson, Jeffrey A. Rappaport, Thomas M. Churilla, Mary Naglak and John C. Flickinger. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Biology & Therapy, Cancer Research and Clinical and Translational Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.